FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199664237> ?p ?o ?g. }

• W3199664237 endingPage "1383" @default.
• W3199664237 startingPage "1383" @default.
• W3199664237 abstract "Progesterone-induced rapid non-genomic signaling events have been confirmed through several membrane progesterone receptors (mPR). Some mPRs were reported to correlate with cancer progression and patient prognosis. In this study, we conducted a comprehensive analysis of all progesterone receptor (PGR)-related genes in prostate cancer tissues and examined the correlations of their expression levels with disease progression and patient survival outcomes. We utilized multiple RNA-seq and cDNA microarray datasets to analyze gene expression profiles and performed logistics aggression and Kaplan-Meier survival analysis after stratifying patients based on tumor stages and Gleason scores. We also used NCBI GEO datasets to examine gene expression patterns in individual cell types of the prostate gland and to determine the androgen-induced alteration of gene expression. Spearman coefficient analysis was conducted to access the correlation of target gene expression with treatment responses and disease progression status. The classic PGR was mainly expressed in stromal cells and progestin and adipoQ receptor (PAQR) genes were the predominant genes in prostate epithelial cells. Progesterone receptor membrane component-1 (PGRMC1) was significantly higher than PGRMC2 in all prostate cell types. In prostate cancer tissues, PAQR6 expression was significantly upregulated, while all other genes were largely downregulated compared to normal prostate tissues. Although both PAQR6 upregulation and PAQR5 downregulation were significantly correlated with tumor pathological stages, only PAQR6 upregulation was associated with Gleason score, free-prostate-specific antigen (fPSA)/total-PSA (tPSA) ratio, and patient overall survival outcomes. In addition, PAQR6 upregulation and PGR/PGRMC1 downregulation were significantly associated with a quick relapse. Conversely, in neuroendocrinal prostate cancer (NEPC) tissues, PAQR6 expression was significantly lower, but PAQR7/8 expression was higher than castration-resistant prostate cancer (CRPC) tissues. PAQR8 expression was positively correlated with androgen receptor (AR) score and AR-V7 expression levels but inversely correlated with NEPC score in metastatic CRPC tumors. This study provides detailed expression profiles of membrane progesterone receptor genes in primary cancer, CRPC, and NEPC tissues. PAQR6 upregulation in primary cancer tissues is a novel prognostic biomarker for disease progression, overall, and progression-free survival in prostate cancers. PAQR8 expression in CRPC tissues is a biomarker for AR activation." @default.
• W3199664237 created "2021-09-27" @default.
• W3199664237 creator A5010421954 @default.
• W3199664237 creator A5034180607 @default.
• W3199664237 creator A5036064727 @default.
• W3199664237 creator A5038625335 @default.
• W3199664237 creator A5039972688 @default.
• W3199664237 creator A5048826252 @default.
• W3199664237 creator A5078621176 @default.
• W3199664237 creator A5084681260 @default.
• W3199664237 date "2021-09-18" @default.
• W3199664237 modified "2023-10-14" @default.
• W3199664237 title "PAQR6 Upregulation Is Associated with AR Signaling and Unfavorite Prognosis in Prostate Cancers" @default.
• W3199664237 cites W1513110684 @default.
• W3199664237 cites W1955008898 @default.
• W3199664237 cites W1988676996 @default.
• W3199664237 cites W1989912756 @default.
• W3199664237 cites W2025183726 @default.
• W3199664237 cites W2027844138 @default.
• W3199664237 cites W2037932659 @default.
• W3199664237 cites W2038696594 @default.
• W3199664237 cites W2051025382 @default.
• W3199664237 cites W2069935005 @default.
• W3199664237 cites W2070156806 @default.
• W3199664237 cites W2077686572 @default.
• W3199664237 cites W2107633226 @default.
• W3199664237 cites W2119857211 @default.
• W3199664237 cites W2142811955 @default.
• W3199664237 cites W2262087934 @default.
• W3199664237 cites W2318341073 @default.
• W3199664237 cites W2754374178 @default.
• W3199664237 cites W2783187175 @default.
• W3199664237 cites W2791908555 @default.
• W3199664237 cites W2795989238 @default.
• W3199664237 cites W2883078202 @default.
• W3199664237 cites W2904355372 @default.
• W3199664237 cites W2914510913 @default.
• W3199664237 cites W2944403040 @default.
• W3199664237 cites W2969913800 @default.
• W3199664237 cites W2973077025 @default.
• W3199664237 cites W2973208486 @default.
• W3199664237 cites W3041255266 @default.
• W3199664237 cites W3125504885 @default.
• W3199664237 cites W3160255312 @default.
• W3199664237 cites W3170981509 @default.
• W3199664237 cites W3185871101 @default.
• W3199664237 doi "https://doi.org/10.3390/biom11091383" @default.
• W3199664237 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8465620" @default.
• W3199664237 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34572596" @default.
• W3199664237 hasPublicationYear "2021" @default.
• W3199664237 type Work @default.
• W3199664237 sameAs 3199664237 @default.
• W3199664237 citedByCount "10" @default.
• W3199664237 countsByYear W31996642372022 @default.
• W3199664237 countsByYear W31996642372023 @default.
• W3199664237 crossrefType "journal-article" @default.
• W3199664237 hasAuthorship W3199664237A5010421954 @default.
• W3199664237 hasAuthorship W3199664237A5034180607 @default.
• W3199664237 hasAuthorship W3199664237A5036064727 @default.
• W3199664237 hasAuthorship W3199664237A5038625335 @default.
• W3199664237 hasAuthorship W3199664237A5039972688 @default.
• W3199664237 hasAuthorship W3199664237A5048826252 @default.
• W3199664237 hasAuthorship W3199664237A5078621176 @default.
• W3199664237 hasAuthorship W3199664237A5084681260 @default.
• W3199664237 hasBestOaLocation W31996642371 @default.
• W3199664237 hasConcept C104317684 @default.
• W3199664237 hasConcept C121608353 @default.
• W3199664237 hasConcept C126322002 @default.
• W3199664237 hasConcept C127561419 @default.
• W3199664237 hasConcept C143998085 @default.
• W3199664237 hasConcept C150194340 @default.
• W3199664237 hasConcept C162317418 @default.
• W3199664237 hasConcept C16930146 @default.
• W3199664237 hasConcept C2776235491 @default.
• W3199664237 hasConcept C2780192828 @default.
• W3199664237 hasConcept C502942594 @default.
• W3199664237 hasConcept C54355233 @default.
• W3199664237 hasConcept C61367390 @default.
• W3199664237 hasConcept C71924100 @default.
• W3199664237 hasConcept C86803240 @default.
• W3199664237 hasConceptScore W3199664237C104317684 @default.
• W3199664237 hasConceptScore W3199664237C121608353 @default.
• W3199664237 hasConceptScore W3199664237C126322002 @default.
• W3199664237 hasConceptScore W3199664237C127561419 @default.
• W3199664237 hasConceptScore W3199664237C143998085 @default.
• W3199664237 hasConceptScore W3199664237C150194340 @default.
• W3199664237 hasConceptScore W3199664237C162317418 @default.
• W3199664237 hasConceptScore W3199664237C16930146 @default.
• W3199664237 hasConceptScore W3199664237C2776235491 @default.
• W3199664237 hasConceptScore W3199664237C2780192828 @default.
• W3199664237 hasConceptScore W3199664237C502942594 @default.
• W3199664237 hasConceptScore W3199664237C54355233 @default.
• W3199664237 hasConceptScore W3199664237C61367390 @default.
• W3199664237 hasConceptScore W3199664237C71924100 @default.
• W3199664237 hasConceptScore W3199664237C86803240 @default.
• W3199664237 hasIssue "9" @default.
• W3199664237 hasLocation W31996642371 @default.
• W3199664237 hasLocation W31996642372 @default.

• next